Explore the dual role of APOBEC3 cytidine deaminases in DNA break repair and cancer promotion - from antiviral defense to cancer mutagenesis.
Discover how IL-6 genetic variants can predict response to bevacizumab treatment in metastatic colorectal cancer patients.
Explore how shared epigenetic regulators control gene expression in both vascular biology and cancer development, revealing new therapeutic opportunities.
Explore how postgenome medicine is transforming cancer treatment by moving beyond DNA sequencing to understand cancer as a dynamic, evolving ecosystem.
Explore the fascinating world of nullomers and nullpeptides - the missing DNA and protein sequences that reveal evolutionary secrets and offer new approaches to cancer detection and treatment.
Explore the role of MITF pathway mutations in melanoma, including phenotype switching, therapeutic resistance, and future research directions.
Discover how the Fli-1 gene and its Fli-1b isoform regulate blood development and contribute to diseases through alternative promoters and differential splicing.
Discover how αB-crystallin, a lens protein, protects against cataracts and cancer by regulating p53 and maintaining genomic stability.
Explore how chromosomal instability creates genetic chaos in melanoma cells, driving treatment resistance and disease progression through evolutionary mechanisms.
Groundbreaking research on neoadjuvant immune checkpoint blockade for malignant pleural mesothelioma treatment, offering new hope for patients.